BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34643575)

  • 1. Prevalence of Iron Deficiency and Iron Administration in Left Ventricular Assist Device and Heart Transplantation Patients.
    Veenis JF; Radhoe SP; Roest S; Caliskan K; Constantinescu AA; Manintveld OC; Brugts JJ
    ASAIO J; 2022 Jul; 68(7):899-906. PubMed ID: 34643575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
    Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous-flow left ventricular assist devices associated survival awaiting heart and heart-kidney transplant.
    Weber MP; O'Malley TJ; Maynes EJ; Choi JH; Morris RJ; Massey HT; Tchantchaleishvili V
    Artif Organs; 2023 Apr; 47(4):770-776. PubMed ID: 36448269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life of advanced chronic heart failure: medical care, mechanical circulatory support and transplantation.
    Emin A; Rogers CA; Banner NR;
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):269-73. PubMed ID: 27107045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
    Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
    Heart Lung Circ; 2017 Feb; 26(2):143-149. PubMed ID: 27523461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.
    Immohr MB; Boeken U; Mueller F; Prashovikj E; Morshuis M; Böttger C; Aubin H; Gummert J; Akhyari P; Lichtenberg A; Schramm R
    ESC Heart Fail; 2021 Apr; 8(2):1253-1262. PubMed ID: 33480186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile left ventricular assist device support as a bridge to decision in patients with end-stage heart failure complicated by pulmonary hypertension.
    Nair PK; Kormos RL; Teuteberg JJ; Mathier MA; Bermudez CA; Toyoda Y; Dew MA; Simon MA
    J Heart Lung Transplant; 2010 Feb; 29(2):201-8. PubMed ID: 20113910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of patients on heart transplant list treated with a continuous-flow left ventricular assist device: Insights from the TRans-Atlantic registry on VAd and TrAnsplant (TRAViATA).
    Ammirati E; Brambatti M; Braun OÖ; Shah P; Cipriani M; Bui QM; Veenis J; Lee E; Xu R; Hong KN; Van de Heyning CM; Perna E; Timmermans P; Cikes M; Brugts JJ; Veronese G; Minto J; Smith S; Gjesdal G; Gernhofer YK; Partida C; Potena L; Masetti M; Boschi S; Loforte A; Jakus N; Milicic D; Nilsson J; De Bock D; Sterken C; Van den Bossche K; Rega F; Tran H; Singh R; Montomoli J; Mondino M; Greenberg B; Russo CF; Pretorius V; Liviu K; Frigerio M; Adler ED
    Int J Cardiol; 2021 Feb; 324():122-130. PubMed ID: 32950592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term preservation of functional capacity and quality of life in advanced heart failure patients with bridge to transplant therapy: A report from Japanese nationwide multicenter registry.
    Sato T; Kobayashi Y; Nagai T; Nakatani T; Kobashigawa J; Saiki Y; Ono M; Wakasa S; Anzai T
    Int J Cardiol; 2022 Jun; 356():66-72. PubMed ID: 35337935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
    Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
    J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing palliative care need in left ventricular assist device patients and heart transplant recipients.
    Strangl F; Ullrich A; Oechsle K; Bokemeyer C; Blankenberg S; Knappe D; Reichenspurner H; Bernhardt AM; Barten MJ; Rybczynski M
    Interact Cardiovasc Thorac Surg; 2020 Dec; 31(6):874-880. PubMed ID: 33155042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current indications for heart transplantation and left ventricular assist device: a practical point of view.
    Ammirati E; Oliva F; Cannata A; Contri R; Colombo T; Martinelli L; Frigerio M
    Eur J Intern Med; 2014 Jun; 25(5):422-9. PubMed ID: 24641806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.